US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.055
- +0.005+0.48%
Close Sep 26 16:00 ET
- 1.070
- +0.015+1.41%
Post 17:55 ET
31.48MMarket Cap-483P/E (TTM)
1.070High1.035Low197.14KVolume1.060Open1.050Pre Close207.71KTurnover1.91%Turnover RatioLossP/E (Static)29.84MShares22.22052wk High0.32P/B10.91MFloat Cap0.87052wk Low--Dividend TTM10.34MShs Float23.580Historical High--Div YieldTTM3.33%Amplitude0.870Historical Low1.053Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
AN2 Therapeutics Stock Forum
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
4 dollar is their initial price
so hopeless at this price now
No comment yet